BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 16720046)

  • 1. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
    Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
    Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2.
    Feniger-Barish R; Ran M; Zaslaver A; Ben-Baruch A
    Cytokine; 1999 Dec; 11(12):996-1009. PubMed ID: 10623425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
    Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
    Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors.
    Allegretti M; Bertini R; Cesta MC; Bizzarri C; Di Bitondo R; Di Cioccio V; Galliera E; Berdini V; Topai A; Zampella G; Russo V; Di Bello N; Nano G; Nicolini L; Locati M; Fantucci P; Florio S; Colotta F
    J Med Chem; 2005 Jun; 48(13):4312-31. PubMed ID: 15974585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional significance behind expressing two IL-8 receptor types on PMN.
    Stillie R; Farooq SM; Gordon JR; Stadnyk AW
    J Leukoc Biol; 2009 Sep; 86(3):529-43. PubMed ID: 19564575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR2--the receptor to hit?
    Reutershan J
    Drug News Perspect; 2006 Dec; 19(10):615-23. PubMed ID: 17299604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue.
    Gijsbers K; Van Assche G; Joossens S; Struyf S; Proost P; Rutgeerts P; Geboes K; Van Damme J
    Eur J Immunol; 2004 Jul; 34(7):1992-2000. PubMed ID: 15214047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
    De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
    Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2.
    Moriconi A; Cesta MC; Cervellera MN; Aramini A; Coniglio S; Colagioia S; Beccari AR; Bizzarri C; Cavicchia MR; Locati M; Galliera E; Di Benedetto P; Vigilante P; Bertini R; Allegretti M
    J Med Chem; 2007 Aug; 50(17):3984-4002. PubMed ID: 17665889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR2 in acute lung injury.
    Konrad FM; Reutershan J
    Mediators Inflamm; 2012; 2012():740987. PubMed ID: 22719179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
    Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM
    J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat.
    Garau A; Bertini R; Mosca M; Bizzarri C; Anacardio R; Triulzi S; Allegretti M; Ghezzi P; Villa P
    Eur Cytokine Netw; 2006 Mar; 17(1):35-41. PubMed ID: 16613761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a new interleukin-8 receptor in bovine species.
    Lahouassa H; Rainard P; Caraty A; Riollet C
    Mol Immunol; 2008 Feb; 45(4):1153-64. PubMed ID: 17727952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and characterization of a neutralizing pan-ELR+CXC chemokine monoclonal antibody.
    Boyles JS; Beidler CB; Strifler BA; Girard DS; Druzina Z; Durbin JD; Swearingen ML; Lee LN; Kikly K; Chintharlapalli S; Witcher DR
    MAbs; 2020; 12(1):1831880. PubMed ID: 33183151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular trafficking of human CXCR1 and CXCR2: regulation by receptor domains and actin-related kinases.
    Matityahu E; Feniger-Barish R; Meshel T; Zaslaver A; Ben-Baruch A
    Eur J Immunol; 2002 Dec; 32(12):3525-35. PubMed ID: 12442335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GCP-2-induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR(+)-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling.
    Feniger-Barish R; Belkin D; Zaslaver A; Gal S; Dori M; Ran M; Ben-Baruch A
    Blood; 2000 Mar; 95(5):1551-9. PubMed ID: 10688807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2.
    Zaslaver A; Feniger-Barish R; Ben-Baruch A
    J Immunol; 2001 Jan; 166(2):1272-84. PubMed ID: 11145710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8((3-74))K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology.
    Zhao X; Li F; Town JR; Zhang X; Wang W; Gordon JR
    Int Immunopharmacol; 2007 Dec; 7(13):1723-31. PubMed ID: 17996682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
    Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
    Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.